Turtles Intrastate and Interstate Requirements; Confirmation of Effective Date, 66841 [2013-26734]

Download as PDF Federal Register / Vol. 78, No. 216 / Thursday, November 7, 2013 / Rules and Regulations the requirements of 16 CFR 1500.18(a)(5) contained in 16 CFR 1500.86(a)(6). The final rule is unchanged from the NPR. PART 1500—HAZARDOUS SUBSTANCES AND ARTICLES; ADMINISTRATION AND ENFORCEMENT REGULATIONS B. Paperwork Reduction Act ■ The final rule does not impose any information collection requirements. Accordingly, this rule is not subject to the Paperwork Reduction Act, 44 U.S.C. 3501–3520. C. Regulatory Flexibility Act 1. The authority citation for 16 CFR part 1500 continues to read as follows: Authority: 15 U.S.C. 1261–1278. § 1500.18 [Amended] 2. Section 1500.18 is amended by removing and reserving paragraph (a)(5). ■ § 1500.47 The Commission certified under the Regulatory Flexibility Act (5 U.S.C. 601–612) that the proposed rule would not have a significant economic impact on a substantial number of small entities because the rule would revoke outdated regulatory requirements. We have received no information to change that certification. ■ [Removed] 3. Section 1500.47 is removed. § 1500.86 [Amended] 66841 In the Federal Register of July 25, 2013 (78 FR 44878 at 44879), FDA solicited comments concerning the direct final rule for a 75-day period ending October 8, 2013. The document published with an incorrect effective date of ‘‘January 16, 2014.’’ In the Federal Register of October 25, 2013 (78 FR 63872), the effective date was corrected to read ‘‘December 9, 2013,’’ 135 days after publication in the Federal Register, unless any significant adverse comment was submitted to FDA during the comment period. FDA did not receive any significant adverse comments. SUPPLEMENTARY INFORMATION: ■ 4. Section 1500.86 is amended by removing and reserving paragraph (a)(6). Authority: 42 U.S.C. 216, 243, 264, 271. Accordingly, the amendments issued thereby are effective. Dated: November 1, 2013. Todd A. Stevenson, Secretary, U.S. Consumer Product Safety Commission. Dated: November 4, 2013. Leslie Kux, Assistant Commissioner for Policy. D. Environmental Considerations [FR Doc. 2013–26618 Filed 11–6–13; 8:45 am] BILLING CODE 4160–01–P This rule falls within the scope of the Commission’s environmental review regulation at 16 CFR 1021.5(c)(1), which provides a categorical exclusion from any requirement for the agency to prepare an environmental assessment or an environmental impact statement for rules that revoke product safety standards. BILLING CODE 6355–01–P E. Executive Order 12988 [Docket No. FDA–2013–N–0639] According to Executive Order 12988 (February 5, 1996), agencies must state in clear language the preemptive effect, if any, of new regulations. The preemptive effect of regulations such as this final rule is stated in section 18 of the FHSA. 15 U.S.C. 1261n. Turtles Intrastate and Interstate Requirements; Confirmation of Effective Date F. Effective Date pmangrum on DSK3VPTVN1PROD with RULES List of Subjects in 16 CFR Part 1500 Consumer protection, Hazardous substances, Imports, Infants and children, Labeling, Law enforcement, Reporting and recordkeeping requirements, Toys. For the reasons stated in the preamble, and under the authority of 15 U.S.C. 1261–1262 and 5 U.S.C. 553, the Consumer Product Safety Commission amends 16 CFR part 1500 as follows: 15:20 Nov 06, 2013 Jkt 232001 AGENCY FOR INTERNATIONAL DEVELOPMENT 22 CFR Part 230 Food and Drug Administration Israel Loan Guarantees Issued Under the Emergency Wartime Supplemental Appropriations Act of 2003—Standard Terms and Conditions 21 CFR Part 1240 AGENCY: Food and Drug Administration, HHS. Direct final rule; confirmation of effective date. ACTION: The Food and Drug Administration (FDA) is confirming the effective date of December 9, 2013, for the final rule that appeared in the Federal Register of July 25, 2013. The direct final rule amends the regulations regarding the prohibition on the sale, or other commercial or public distribution, of viable turtle eggs and live turtles with a carapace length of less than 4 inches to remove procedures for destruction. This document confirms the effective date of the direct final rule. DATES: The December 9, 2013, effective date for the final rule published July 25, 2013 (78 FR 44878), corrected October 25, 2013 (78 FR 63872), is confirmed. FOR FURTHER INFORMATION CONTACT: Dillard Woody, Center for Veterinary Medicine (HFV–231), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240–276–9237, email: dillard.woody@fda.hhs.gov. SUMMARY: The Commission proposed that the rule revoking 16 CFR 1500.18(a)(5), 1500.47, and 1500.86(a)(6) become effective 30 days after publication of the final rule in the Federal Register. We received no comments on the effective date. Therefore, the final rule will become effective 30 days after publication in the Federal Register. VerDate Mar<15>2010 DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2013–26734 Filed 11–6–13; 8:45 am] PO 00000 Frm 00017 Fmt 4700 Sfmt 4700 Agency for International Development (USAID). ACTION: Final rule. AGENCY: This regulation prescribes the revised procedures and revised standard terms and conditions applicable to loan guarantees issued for the benefit of the Government of Israel on behalf of the State of Israel. Pursuant to the Emergency Wartime Supplemental Appropriations Act of 2003, the United States of America, acting through the U.S. Agency for International Development, may issue loan guarantees applicable to sums borrowed by the Government of Israel on behalf of the State of Israel (the ‘‘Borrower’’). The loan guarantees were originally issued pursuant to a Loan Guarantee Commitment Agreement between the Borrower and the United States Government dated August 18, 2003 and applied to sums borrowed from time to time between March 1, 2003 and September 30, 2006. Pursuant to an Amended and Restated Loan Guarantee Commitment Agreement dated October 24, 2012, the loan guarantees will now apply to sums borrowed from time to time between March 1, 2003 and September 30, 2016. SUMMARY: E:\FR\FM\07NOR1.SGM 07NOR1

Agencies

[Federal Register Volume 78, Number 216 (Thursday, November 7, 2013)]
[Rules and Regulations]
[Page 66841]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-26734]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 1240

[Docket No. FDA-2013-N-0639]


Turtles Intrastate and Interstate Requirements; Confirmation of 
Effective Date

AGENCY: Food and Drug Administration, HHS.

ACTION: Direct final rule; confirmation of effective date.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is confirming the 
effective date of December 9, 2013, for the final rule that appeared in 
the Federal Register of July 25, 2013. The direct final rule amends the 
regulations regarding the prohibition on the sale, or other commercial 
or public distribution, of viable turtle eggs and live turtles with a 
carapace length of less than 4 inches to remove procedures for 
destruction. This document confirms the effective date of the direct 
final rule.

DATES: The December 9, 2013, effective date for the final rule 
published July 25, 2013 (78 FR 44878), corrected October 25, 2013 (78 
FR 63872), is confirmed.

FOR FURTHER INFORMATION CONTACT: Dillard Woody, Center for Veterinary 
Medicine (HFV-231), Food and Drug Administration, 7519 Standish Pl., 
Rockville, MD 20855, 240-276-9237, email: dillard.woody@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In the Federal Register of July 25, 2013 (78 
FR 44878 at 44879), FDA solicited comments concerning the direct final 
rule for a 75-day period ending October 8, 2013. The document published 
with an incorrect effective date of ``January 16, 2014.'' In the 
Federal Register of October 25, 2013 (78 FR 63872), the effective date 
was corrected to read ``December 9, 2013,'' 135 days after publication 
in the Federal Register, unless any significant adverse comment was 
submitted to FDA during the comment period. FDA did not receive any 
significant adverse comments.

    Authority:  42 U.S.C. 216, 243, 264, 271. Accordingly, the 
amendments issued thereby are effective.

    Dated: November 4, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-26734 Filed 11-6-13; 8:45 am]
BILLING CODE 4160-01-P